The Depo-Provera Litigation (MDL 3140) absorbed 76 new filings on March 18, with OnderLaw LLC driving the surge through 40 individual complaints, cementing its position as the dominant early filer in the newly consolidated meningioma docket before Judge M. Casey Rodgers in the Northern District of Florida. Nigh Goldenberg Raso Vaughn PLLC added 6 cases, while Weitz & Luxenberg PC, Seeger Weiss, and Johnson Law Group contributed 3 filings each. The coordinated assault on Pfizer's long-acting contraceptive — now alleging brain tumor risks after decades on market — signals plaintiffs' leadership is moving aggressively to populate the docket before initial case management conferences set the pace for discovery and bellwether selection.
Peiffer Wolf executed a 97-complaint coordinated filing blitz in the Suboxone Film Litigation (MDL 3092) on March 18, the largest single-day surge in the dental decay docket since consolidation. The filings allege Indivior's buprenorphine/naloxone film causes catastrophic tooth damage through sublingual acidity, with plaintiffs claiming deliberate failure-to-warn violations. The filing volume suggests leadership is preparing for potential bellwether trials while Indivior faces parallel state court pressure.
A federal appellate court addressed coverage questions in the EtO Sterilization Litigation on March 19, ruling on pollution exclusion and permitted emissions issues that directly impact insurer liability for ethylene oxide exposure claims. The decision comes as the EPA's March 13 regulatory rollback on ethylene oxide emission limits continues to reshape the litigation landscape, potentially undermining defense arguments that plaintiffs' exposures fell within permitted regulatory thresholds.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
